Speciality: Family Physicians
Description:
A warm welcome to all the medical professionals in this interesting session on Unexplained Drowsiness in a Case of Stroke
Clinical Presentation and Concerns:
Unexplained drowsiness in a patient with a stroke is a significant clinical concern that necessitates immediate investigation. Drowsiness or altered mental status in the context of a stroke can indicate the severity and extent of brain injury. It may result from direct damage to brain regions responsible for consciousness, such as the reticular activating system, or secondary effects like increased intracranial pressure, edema, or hemorrhagic transformation of an ischemic stroke.
Potential Causes:
Several factors can contribute to drowsiness in stroke patients. These include cerebral hypoperfusion, metabolic imbalances, or infections like pneumonia or urinary tract infections, which are common post-stroke complications. Medication side effects, particularly from sedatives or anticonvulsants used to manage post-stroke seizures, can also cause drowsiness. Additionally, comorbid conditions such as dehydration, electrolyte imbalances, or renal dysfunction should be considered.
Diagnostic Approach:
Evaluating unexplained drowsiness in a stroke patient involves a comprehensive assessment, including a thorough clinical history, neurological examination, and appropriate diagnostic tests. Imaging studies such as CT or MRI scans are crucial to identify potential complications like hemorrhage or new ischemic events. Blood tests, including complete blood count, electrolytes, renal
See More Webinars @ Hidoc Webinars
1.
In leukemia, allogeneic HCT is beneficial following primary induction failure.
2.
Team finds broken 'brake' on cancer mutation machine.
3.
Omega Fatty Acid Changes Tied to Lower Proliferation Rate in Early Prostate Cancer
4.
Prostate cancer screening program beneficial in top decile of polygenic risk score
5.
Talk About Medication Costs, Bringing Back Touch, and Understanding From Dish Tumors.
1.
New Research on Craniopharyngioma
2.
What Is May-Hegglin Anomaly? Understanding this Rare Blood Disorder
3.
A Closer Look at White Blood Cells in Urine: Uncovering the Causes and Treatments
4.
The Expanding Horizon of PSMA: A Comparative Clinical Review of Theranostics in Prostate Cancer and Beyond
5.
The Mysterious World of Petechiae: Exploring Causes and Treatments
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part VI
2.
A New Era in Managing Cancer-Associated Thrombosis
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V
4.
Navigating the Complexities of Ph Negative ALL - Part XV
5.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation